ImMAGE Biotherapeutics Corporation announced that it has received $500,000 in seed round of funding from existing investor Coventry International Limited on March 9, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2017 | ImMAGE Biotherapeutics Announces Termination of Operations | CI |
2017 | ImMAGE Biotherapeutics Initiates Repeat Toxicology Study for Lead Candidate, IMT-001 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 151 | |
+6.11% | 105B | |
-4.67% | 63.83B | |
+73.81% | 45.28B | |
+15.46% | 38.93B | |
+5.46% | 33.06B | |
+11.59% | 20.21B | |
+13.74% | 16.94B | |
+20.05% | 16.08B | |
+5.02% | 14.49B |
- Stock Market
- Equities
- IMMG Stock
- News Immage Biotherapeutics Corp.
- Immage Biotherapeutics Corp. announced that it has received $0.5 million in funding from Coventry International Limited